Chronic Myeloid Leukemia (for Part B and C)

specific

Chronic myelogenous leukaemia (CML) is a biphasic disease, initiated by expression of the BCR/ABL fusion gene product in self-renewing, haematopoietic stem cells (HSCs). HSCs can differentiate into common myeloid progenitors (CMPs), which then differentiate into granulocyte/macrophage progenitors (GMPs). HSCs can also differentiate into common lymphoid progenitors (CLPs), which are the progenitors of lymphocytes such as T cells and B cells. The initial chronic phase of CML (CML-CP) is characteri

3

Centers

3

Active Trials

—

Cancer Funding

Top Centers for Chronic Myeloid Leukemia (for Part B and C)(3)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
Memorial Sloan Kettering Cancer CenterNew York, NY
NCI Comprehensive
Active Research Program
66.7
2
The University of Texas MD Anderson Cancer CenterHouston, TX
NCI Comprehensive
Active Research Program
66.7
3
Georgia Cancer Center, Augusta UniversityAugusta, GA
Active Research Program
66.7

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →